<DOC>
	<DOC>NCT00414661</DOC>
	<brief_summary>The purpose of this study is to follow the health of subjects who have previously been enrolled in studies of CP-690,550 for treatment of their rheumatoid arthritis. Subjects are only eligible for this study after they have completed all participation in other studies of CP-690,550.</brief_summary>
	<brief_title>Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550</brief_title>
	<detailed_description>At their last visit of a qualifying study, eligible subjects will be given the opportunity to participate in this study.</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Subjects who have completed all participation in any other Phase 2B or Phase 3 studies of CP690,550 for rheumatoid arthritis. Any subject who refuses consent.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Observational non-interventional long-term safety</keyword>
</DOC>